Edition:
United States

Insider Trading: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

27.79USD
5 Dec 2016
Change (% chg)

$0.64 (+2.36%)
Prev Close
$27.15
Open
$27.68
Day's High
$28.78
Day's Low
$27.33
Volume
1,924,298
Avg. Vol
2,331,541
52-wk High
$42.49
52-wk Low
$16.64

BAKER BROS ADVISORS L P
Trading Date Type Shares Traded Price Shares Held
9 Aug 2016 Buy 133,153 $33.00 25,819,768
9 Aug 2016 Buy 1,169,877 $33.00 25,819,768
31 Mar 2016 Buy 1,182 $27.82 44,794,746
31 Mar 2016 Buy 262,253 $28.55 44,794,746
31 Mar 2016 Buy 10,818 $27.82 44,794,746
31 Mar 2016 Buy 28,647 $28.55 44,794,746
30 Mar 2016 Buy 1,614 $25.61 44,794,746
30 Mar 2016 Buy 19,676 $26.49 44,794,746
30 Mar 2016 Buy 1,467 $26.29 44,794,746
30 Mar 2016 Buy 13,433 $26.29 44,794,746
30 Mar 2016 Buy 34,844 $27.72 44,794,746
30 Mar 2016 Buy 180,122 $26.49 44,794,746
30 Mar 2016 Buy 28,433 $26.55 44,794,746
30 Mar 2016 Buy 318,969 $27.72 44,794,746
30 Mar 2016 Buy 3,106 $26.55 44,794,746
30 Mar 2016 Buy 60,587 $27.56 44,794,746
30 Mar 2016 Buy 14,775 $25.61 44,794,746
30 Mar 2016 Buy 6,618 $27.56 44,794,746
29 Mar 2016 Buy 408,607 $25.92 44,794,746
29 Mar 2016 Buy 16,057 $26.35 44,794,746
29 Mar 2016 Buy 37,882 $25.98 44,794,746
6 Jan 2016 Buy 1,801,161 $29.00 20,730,548
6 Jan 2016 Buy 785,045 $29.00 20,730,548

Institutional Holders

% Shares Owned: 99.20%
# of Holders: 332
Total Shares Held: 120,147,104
3 Mo. Net Change: 6,683,243
# New Positions: 37
# Closed Positions: 28
# Increased Positions: 142
# Reduced Positions: 120
# Net Buyers: 22

Officers & Directors

Name Age Since Current Position

Stephen Biggar

45 2016 Chairman of the Board

Stephen Davis

55 2016 President, Chief Executive Officer, Director

Todd Young

44 2016 Chief Financial Officer, Executive Vice President, Principal Financial Officer and Principal Accounting Officer

Glenn Baity

45 2014 Executive Vice President, General Counsel, Secretary

Terrence Moore

60 2013 Executive Vice President, Chief Commercial Officer

Srdjan Stankovic

58 2015 Executive Vice President, Head - Research and Development

Julian Baker

50 2015 Director

James Daly

2016 Director

Edmund Harrigan

56 2015 Director

Laura Brege

58 2008 Independent Director

Daniel Soland

56 2015 Independent Director

Lisa Barthelemy

2015 Director, Investor Relations